Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The aim of this study is to evaluate RBV plasma concentrations when used in combination with newly developed DAA combinations. If possible, its correlations with SVR rates and incidence of anaemia will be assessed in HCV-patients.
Epistemonikos ID: a62cb06b9ae3608a9604ad5dee43428a617b6de1
First added on: May 12, 2024